Actinium Appoints Senior Director Of Finance And Corporate Development
This article was originally published in Scrip
Actinium Pharmaceuticals, Inc. has appointed Steve O'Loughlin senior director of finance and corporate development. Most recently, O'Loughlin was vice-president of corporate finance and development and a corporate officer at Protea Biosciences, Inc. He has also previously held corporate development positions with Caliber I.D. and worked in investment banking at Jesup & Lamont.